Peter A. LeWitt

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Christopher G. Goetz, Barbara C. Tilley, Stephanie R. Shaftman et al. · Movement Disorders · 2008 · 7.5K citations · Full text

Medicine, Neurology, Functional Movement Assessment +16

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Process, format, and clinimetric testing plan

Christopher G. Goetz, Stanley Fahn, Pablo Martínez‐Martín et al. · Movement Disorders · 2006 · 1.4K citations · Full text

Medicine, Neurology, Clinical Neuroscience +13

Pramipexole vs Levodopa as initial treatment for Parkinson disease: A randomized controlled trial

Robert G. Holloway, Ira Shoulson, Karl Kieburtz et al. · JAMA · 2000 · 802 citations

Medicine, Neurology, Pharmacotherapy +12

AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial

Peter A. LeWitt, Ali R. Rezai, Maureen A. Leehey et al. · The Lancet Neurology · 2011 · 672 citations

Medicine, Neurology, Neuroscience +13

Adenosine A _2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)

Peter A. LeWitt, Mark Guttman, James W. Tetrud et al. · Annals of Neurology · 2008 · 350 citations

Medicine, Neurology, Pharmacology +13